154 related articles for article (PubMed ID: 37119412)
1. Genetic polymorphism between the Sorani and Hawrami kurdish populations and COVID-19 outcome.
Rashid PMA; Salih GF
Mol Biol Rep; 2023 Jun; 50(6):5177-5183. PubMed ID: 37119412
[TBL] [Abstract][Full Text] [Related]
2. The significance of IFITM3 polymorphism in COVID-19 asymptomatic and ICU admission Kurdish patients.
Rashid PMA; Salih GF
Cytokine; 2023 Nov; 171():156349. PubMed ID: 37683443
[TBL] [Abstract][Full Text] [Related]
3. The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19.
Schönfelder K; Breuckmann K; Elsner C; Dittmer U; Fistera D; Herbstreit F; Risse J; Schmidt K; Sutharsan S; Taube C; Jöckel KH; Siffert W; Kribben A; Möhlendick B
Cytokine; 2021 Jun; 142():155492. PubMed ID: 33711707
[TBL] [Abstract][Full Text] [Related]
4. Ethnic variation in risk genotypes based on single nucleotide polymorphisms (SNPs) of the interferon-inducible transmembrane 3 (IFITM3) gene, a susceptibility factor for pandemic 2009 H1N1 influenza A virus.
Kim YC; Jeong BH
Immunogenetics; 2020 Dec; 72(9-10):447-453. PubMed ID: 33174121
[TBL] [Abstract][Full Text] [Related]
5. Interferon-Induced Transmembrane Protein-3 Rs12252-G Variant Increases COVID-19 Mortality Potential in Egyptian Population.
Elessawy SM; Shehab A; Soliman DA; Eldeeb MA; Taha SI
Viral Immunol; 2024 May; 37(4):186-193. PubMed ID: 38717821
[TBL] [Abstract][Full Text] [Related]
6. Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.
David S; Correia V; Antunes L; Faria R; Ferrão J; Faustino P; Nunes B; Maltez F; Lavinha J; Rebelo de Andrade H
Immunogenetics; 2018 Mar; 70(3):169-177. PubMed ID: 28842783
[TBL] [Abstract][Full Text] [Related]
7. Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (
Kim YC; Jeong BH
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33396837
[TBL] [Abstract][Full Text] [Related]
8. No Correlation of the Disease Severity of Influenza A Virus Infection with the rs12252 Polymorphism of the Interferon-Induced Transmembrane Protein 3 Gene.
Kim YC; Jeong BH
Intervirology; 2017; 60(1-2):69-74. PubMed ID: 28813716
[TBL] [Abstract][Full Text] [Related]
9. SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.
Allen EK; Randolph AG; Bhangale T; Dogra P; Ohlson M; Oshansky CM; Zamora AE; Shannon JP; Finkelstein D; Dressen A; DeVincenzo J; Caniza M; Youngblood B; Rosenberger CM; Thomas PG
Nat Med; 2017 Aug; 23(8):975-983. PubMed ID: 28714988
[TBL] [Abstract][Full Text] [Related]
10. Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis.
Li Y; Wei L; He L; Sun J; Liu N
J Infect; 2022 Jun; 84(6):825-833. PubMed ID: 35461906
[TBL] [Abstract][Full Text] [Related]
11. Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis.
Yang X; Tan B; Zhou X; Xue J; Zhang X; Wang P; Shao C; Li Y; Li C; Xia H; Qiu J
PLoS One; 2015; 10(5):e0124985. PubMed ID: 25942469
[TBL] [Abstract][Full Text] [Related]
12. IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza.
Lee N; Cao B; Ke C; Lu H; Hu Y; Tam CHT; Ma RCW; Guan D; Zhu Z; Li H; Lin M; Wong RYK; Yung IMH; Hung TN; Kwok K; Horby P; Hui DSC; Chan MCW; Chan PKS
J Infect Dis; 2017 Jul; 216(1):97-104. PubMed ID: 28510725
[TBL] [Abstract][Full Text] [Related]
13. Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality.
Ahmadi I; Afifipour A; Sakhaee F; Zamani MS; Mirzaei Gheinari F; Anvari E; Fateh A
Cytokine; 2022 Sep; 157():155957. PubMed ID: 35792282
[TBL] [Abstract][Full Text] [Related]
14. Interferon-Induced Transmembrane Protein 3 rs34481144 C/T Genotype and Clinical Parameters Related to Progression of COVID-19.
Gholami M; Sakhaee F; Mirzaei Gheinari F; Sotoodehnejadnematalahi F; Ghazanfari Jajin M; Zamani MS; Ahmadi I; Anvari E; Fateh A
J Immunol Res; 2023; 2023():2345062. PubMed ID: 37323564
[TBL] [Abstract][Full Text] [Related]
15.
Pan Y; Yang P; Dong T; Zhang Y; Shi W; Peng X; Cui S; Zhang D; Lu G; Liu Y; Wu S; Wang Q
Front Cell Infect Microbiol; 2017; 7():294. PubMed ID: 28713779
[No Abstract] [Full Text] [Related]
16. The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19.
Gómez J; Albaiceta GM; Cuesta-Llavona E; García-Clemente M; López-Larrea C; Amado-Rodríguez L; López-Alonso I; Melón S; Alvarez-Argüelles ME; Gil-Peña H; Vidal-Castiñeira JR; Corte-Iglesias V; Saiz ML; Alvarez V; Coto E
Cytokine; 2021 Jan; 137():155354. PubMed ID: 33113474
[TBL] [Abstract][Full Text] [Related]
17. Association between the interferon-induced transmembrane protein 3 gene (
Cuesta-Llavona E; Albaiceta GM; García-Clemente M; Duarte-Herrera ID; Amado-Rodríguez L; Hermida-Valverde T; Enríquez-Rodriguez AI; Hernández-González C; Melón S; Alvarez-Argüelles ME; Boga JA; Rojo-Alba S; Vázquez-Coto D; Gómez J; Coto E
Curr Res Virol Sci; 2021; 2():100016. PubMed ID: 34870250
[TBL] [Abstract][Full Text] [Related]
18. The frequency of combined IFITM3 haplotype involving the reference alleles of both rs12252 and rs34481144 is in line with COVID-19 standardized mortality ratio of ethnic groups in England.
Nikoloudis D; Kountouras D; Hiona A
PeerJ; 2020; 8():e10402. PubMed ID: 33240681
[TBL] [Abstract][Full Text] [Related]
19. Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission.
Carter TC; Hebbring SJ; Liu J; Mosley JD; Shaffer CM; Ivacic LC; Kopitzke S; Stefanski EL; Strenn R; Sundaram ME; Meece J; Brilliant MH; Ferdinands JM; Belongia EA
J Med Virol; 2018 Mar; 90(3):436-446. PubMed ID: 29053189
[TBL] [Abstract][Full Text] [Related]
20. Association of IFITM3 rs12252 polymorphisms, BMI, diabetes, and hypercholesterolemia with mild flu in an Iranian population.
Mehrbod P; Eybpoosh S; Fotouhi F; Shokouhi Targhi H; Mazaheri V; Farahmand B
Virol J; 2017 Nov; 14(1):218. PubMed ID: 29121968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
